Skip to main content
Filing year 2023

NATIONAL SCLERODERMA FOUNDATION INC

Danvers, Massachusetts·EIN 52-1375827·NTEE H400 · Medical Research·3
Total revenue
$4.9M
Total assets
$11.2M
Total expenses
$0
Reported officers
19
Mission

THE NATIONAL SCLERODERMA FOUNDATION'S MISSION IS TO ADVANCE MEDICAL RESEARCH, PROMOTE DISEASE AWARENESS, AND PROVIDE SUPPORT AND EDUCATION TO PEOPLE WITH SCLERODERMA, THEIR FAMILIES AND SUPPORT NETWORKS.

Executive compensation, broken down

Form 990 · Schedule J · 3 reported individuals · Filing year 2023

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
VP of Finance
vice president
$192k
VP of Community Engagement
vice president
$150k

Plus 16 unpaid individuals.

Browse compensation in Medical Research

Up 4%
from 2022

From $243k in 2022 to $254k in 2023.

$243k
2022
$254k
2023
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.